Dr. Aledort is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1140 madison ave
Mount Sinai Hospital Ruttenberg Treatment Center Hem
New York, NY 10029Phone+1 212-860-0205Fax+1 212-987-3326- Is this information wrong?
Education & Training
- University of RochesterResidency, Internal Medicine, 1963 - 1964
- University of Virginia Medical CenterResidency, Internal Medicine, 1959 - 1961
- Albert Einstein College of MedicineClass of 1959
Certifications & Licensure
- NY State Medical License 1963 - 2025
- FL State Medical License 2016 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Super Doctor SuperDoctors.com
Clinical Trials
- Cooperative Study of Factor VIII Inhibitors Start of enrollment: 1978 Jul 01
Publications & Presentations
PubMed
- 4 citationsNew directions to develop therapies for people with hemophilia.Pooja Gogia, Michael Tarantino, Wolfgang Schramm, Louis Aledort> ;Expert Review of Hematology. 2023 Jun 1
- Are all licensed haemostatic agents for haemophilia therapy accessible to patients?Karin Berger, Angelika Batorova, Rhonda Bohn, Matteo di Minno, Pier Mannuccio Mannucci, Kaan Kavakli, Wolfgang Schramm, Louis Aledort> ;Haemophilia. 2022 Nov 1
- In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended-half-life FVIII products or not?Erik Berntorp, Snejana Krassova, Louis M. Aledort> ;Haemophilia. 2021 Sep 8
- Join now to see all
Journal Articles
- Research Paper Application of Phospho-CyTOF to Characterize Immune Activation in Patients with Sickle Cell Disease in an Ex Vivo Model of ThrombosisLouis Aledort, MD, ScienceDirect
Press Mentions
- Hemophilia Drug Hemlibra: Adverse Events Reports and Patient Deaths Raise Some ConcernsDecember 10th, 2019
Grant Support
- Safety And Clinical Efficacy Of Recombinant DNA Derived Factor VIIINational Center For Research Resources1993–1994
- Intranasal Ddavp Spray In Mild Hemophilia And Von Willebrand'S DiseaseNational Center For Research Resources1992
- Safety &Clinical Efficacy Of Recombinant DNA Derived Factor VIIINational Center For Research Resources1990–1992
- Recovery And Half-Life Studies Of Factor VII, VIII And IXNational Center For Research Resources1990–1991
- IVIG In Treatment Of Autoimmune &Alloimmune Antibodies To Coagulation FactorsNational Center For Research Resources1990–1991
- Immunoabsorption For Inhibitors To Factors VIII And IXNational Center For Research Resources1990
- Study Of IV Gamma Globulin For Treatment Of Autoimmune/Alloimmune AntibodiesNational Center For Research Resources1989
- Immunoabsorption For Inhibitors To Factors VIII And VNational Center For Research Resources1988–1989
Hospital Affiliations
- The Mount Sinai HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: